Optimizing multiparametric magnetic resonance imaging-targeted biopsy and detection of clinically significant prostate cancer: the role of perilesional sampling.
Jean-Paul NoujeimYassir BelahsenYolene LefebvreMarc LemortMaxime DeforcheNicolas SirtaineRobin MartinThierry RoumeguereAlexandre PeltierRomain DiamandPublished in: Prostate cancer and prostatic diseases (2022)
Perilesional biopsy template using a 10 mm margin seems a reasonable alternative to the combined method with a comparable detection of csPCa. Our risk stratification may further enhance the selection of patients.
Keyphrases
- prostate cancer
- magnetic resonance imaging
- end stage renal disease
- newly diagnosed
- ultrasound guided
- ejection fraction
- chronic kidney disease
- loop mediated isothermal amplification
- real time pcr
- fine needle aspiration
- peritoneal dialysis
- radical prostatectomy
- computed tomography
- cancer therapy
- high resolution
- mass spectrometry
- magnetic resonance
- patient reported outcomes
- patient reported
- sensitive detection
- quantum dots